• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过皮肤吸收东莨菪碱预防实验性晕动病。

Prevention of experimental motion sickness by scopolamine absorbed through the skin.

作者信息

Graybiel A, Knepton J, Shaw J

出版信息

Aviat Space Environ Med. 1976 Oct;47(10):1096-100.

PMID:791234
Abstract

A double-blind placebo-controlled study compared the efficacy of the antimotion sickness drug scopolamine when administered by oral or transdermal routes. A secondary purpose was to extend our bioassay involving fixed-dose combinations of the homergic drugs promethazine and ephedrine. After receiving 12 apparently identical drug-placebo treatments, eight normal male students were exposed to a slow rotation room to stressful accelerations generated by their execution of 40 head movements out of the plane of the room's rotation of 1 rpm and at 1-rpm increments until either symptoms were experienced (just short of frank motion sickness) or the 27-rpm ceiling on the test was reached. Efficacy of a drug was defined in terms of the placeborange and categorized as beneficial, inconsequential, or detrimental. The rank order of drugs with beneficial effects was: 1) promethazine 25 mg plus ephedrine 12.5 mg (86%); 2) scopolamine by mouth (75%); 3) scopolamine transdermally (63%); and 4) promethazine 12.5 mg plus ephedrine 25 mg (29%). The only detrimental effect was with scopolamine given orally. It is concluded that the advantages of the transdermal scopolamine, which include minimal side effects and prolonged effectiveness, deserve full exploitation.

摘要

一项双盲安慰剂对照研究比较了抗晕动病药物东莨菪碱经口服或经皮给药的疗效。第二个目的是扩展我们涉及同型药物异丙嗪和麻黄碱固定剂量组合的生物测定。在接受12次明显相同的药物 - 安慰剂治疗后,8名正常男学生被置于一个缓慢旋转的房间,通过在与房间旋转平面成一定角度的平面内以1转/分钟的速度进行40次头部运动,并以1转/分钟的增量产生应激加速度,直到出现症状(接近明显晕动病)或达到测试的27转/分钟上限。药物疗效根据安慰剂范围来定义,并分为有益、无关紧要或有害。具有有益效果的药物排名顺序为:1)25毫克异丙嗪加12.5毫克麻黄碱(86%);2)口服东莨菪碱(75%);3)经皮东莨菪碱(63%);4)12.5毫克异丙嗪加25毫克麻黄碱(29%)。唯一有害的效果是口服东莨菪碱。结论是,经皮东莨菪碱的优点,包括副作用最小和疗效持久,值得充分利用。

相似文献

1
Prevention of experimental motion sickness by scopolamine absorbed through the skin.通过皮肤吸收东莨菪碱预防实验性晕动病。
Aviat Space Environ Med. 1976 Oct;47(10):1096-100.
2
Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.实验性晕动病:透皮东莨菪碱加麻黄碱的疗效
Aviat Space Environ Med. 1981 Jun;52(6):337-9.
3
Human assay of antimotion sickness drugs.抗晕动病药物的人体试验。
Aviat Space Environ Med. 1975 Sep;46(9):1107-18.
4
Mechanisms of antimotion sickness drugs.抗晕动病药物的作用机制。
Aviat Space Environ Med. 1987 Sep;58(9 Pt 2):A262-5.
5
Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.东莨菪碱经皮给药12小时和72小时后的抗晕动病疗效。
Aviat Space Environ Med. 1982 Aug;53(8):770-2.
6
Pharmacological interventions for motion sickness: cardiovascular effects.晕动病的药物干预:心血管效应
Aviat Space Environ Med. 1987 Sep;58(9 Pt 2):A270-6.
7
Effect of transdermally administered scopolamine in preventing motion sickness.经皮给药东莨菪碱预防晕动病的效果。
Aviat Space Environ Med. 1979 Nov;50(11):1108-11.
8
Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.东莨菪碱单独或与麻黄碱联合用于晕船:一项双盲、安慰剂对照研究。
Aviat Space Environ Med. 1981 Jan;52(1):6-10.
9
Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.东莨菪碱透皮治疗系统(TTSS)、茶苯海明和安慰剂——海上的一项对比研究。
Aviat Space Environ Med. 1984 Nov;55(11):1051-4.
10
Side effects of antimotion sickness drugs.抗晕动病药物的副作用。
Aviat Space Environ Med. 1984 Feb;55(2):113-6.

引用本文的文献

1
Antihistamines for motion sickness.抗组胺药治疗晕动病。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD012715. doi: 10.1002/14651858.CD012715.pub2.
2
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.用于增强剂量控制和组织靶向的纳米颗粒介导的透皮给药系统
Molecules. 2016 Dec 15;21(12):1719. doi: 10.3390/molecules21121719.
3
Transdermal patches: history, development and pharmacology.透皮贴剂:历史、发展与药理学
Br J Pharmacol. 2015 May;172(9):2179-209. doi: 10.1111/bph.13059. Epub 2015 Mar 18.
4
Motion sickness: more than nausea and vomiting.晕动病:不止恶心与呕吐。
Exp Brain Res. 2014 Aug;232(8):2493-510. doi: 10.1007/s00221-014-4008-8. Epub 2014 Jun 25.
5
Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.用于预防晕动病的透皮东莨菪碱:临床药代动力学及治疗应用
Clin Pharmacokinet. 2006;45(6):543-66. doi: 10.2165/00003088-200645060-00001.
6
Rate-controlled drug dosage.速率控制的药物剂量。
Drugs. 1982 Mar;23(3):207-26. doi: 10.2165/00003495-198223030-00003.
7
Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.东莨菪碱和麻黄碱对健康人的精神运动、生理及认知影响
Eur J Clin Pharmacol. 1983;24(5):603-9. doi: 10.1007/BF00542208.
8
Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer.经皮给予甲溴东莨菪碱对十二指肠溃疡患者夜间胃酸分泌的影响。
Br Med J (Clin Res Ed). 1982 Jun 12;284(6331):1736-8. doi: 10.1136/bmj.284.6331.1736.
9
Effects of transdermal scopolamine upon psychological test performance at sea.透皮东莨菪碱对海上心理测试表现的影响。
Eur J Clin Pharmacol. 1985;28(4):419-23. doi: 10.1007/BF00544360.
10
Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.透皮东莨菪碱(东莨菪碱)。对其药效学特性和治疗效果的初步综述。
Drugs. 1985 Mar;29(3):189-207. doi: 10.2165/00003495-198529030-00001.